Published in J Cell Mol Med on February 04, 2008
Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia. Eye (Lond) (2011) 1.13
Relationship between the expression of cyclooxygenase-2 and survivin in primary pterygium. Mol Vis (2009) 0.86
Induction of endothelial RAGE expression in pterygium. Mol Vis (2014) 0.79
Peroxiredoxin I and II in human eyes: cellular distribution and association with pterygium and DNA damage. J Histochem Cytochem (2013) 0.79
Autonomous inhibition of apoptosis correlates with responsiveness of colon carcinoma cell lines to ciglitazone. PLoS One (2014) 0.78
EphB4 expression in pterygium is associated with microvessel density. Int J Clin Exp Med (2014) 0.77
HMGB1 in the pathogenesis of ultraviolet-induced ocular surface inflammation. Cell Death Dis (2015) 0.75
Survivin and p53 expression in primary and recurrent pterygium in Chinese patients. Int J Ophthalmol (2011) 0.75
p53, the cellular gatekeeper for growth and division. Cell (1997) 31.04
Live or let die: the cell's response to p53. Nat Rev Cancer (2002) 15.06
Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem (2001) 4.21
Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res (1998) 3.63
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene (2002) 3.12
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest (2004) 2.59
Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther (2006) 2.55
UV-induced skin damage. Toxicology (2003) 2.45
Pterygium and ultraviolet radiation: a positive correlation. Br J Ophthalmol (1984) 2.06
The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med (2001) 1.95
Risk analysis in the development of pterygia. Ophthalmology (1992) 1.79
Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog (1991) 1.70
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer. Cell Mol Life Sci (2002) 1.65
Survivin study: an update of "what is the next wave"? J Cell Physiol (2006) 1.63
Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med (1999) 1.58
The pathogenesis of pterygia. Curr Opin Ophthalmol (1999) 1.55
P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors. Curr Eye Res (1997) 1.53
Pterygium: prevalence, demography and risk factors. Ophthalmic Epidemiol (1999) 1.43
Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol (2000) 1.40
Separating the anti-apoptotic and mitotic roles of survivin. J Biol Chem (2006) 1.40
Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome. J Mol Med (Berl) (2007) 1.40
Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol (1997) 1.39
Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest (1999) 1.31
Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol (2005) 1.30
UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci (2002) 1.28
Molecular genetic alterations and viral presence in ophthalmic pterygium. Int J Mol Med (2000) 1.27
Solar keratosis, pterygium, and squamous cell carcinoma of the conjunctiva in Malawi. Br J Ophthalmol (1979) 1.27
DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. J Pharmacol Exp Ther (2002) 1.26
Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J Invest Dermatol (1999) 1.22
Human papillomavirus in pterygium. Br J Ophthalmol (2001) 1.22
The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium. Am J Pathol (2003) 1.19
Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine. Mol Vis (2006) 1.18
Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci (2000) 1.17
Immunologic basis for the pathogenesis of pterygium. Am J Ophthalmol (1984) 1.16
Angiogenesis in pterygium: morphometric and immunohistochemical study. Curr Eye Res (2002) 1.16
8-hydroxy-2'-deoxyguanosine is increased in epidermal cells of hairless mice after chronic ultraviolet B exposure. J Invest Dermatol (1996) 1.13
Detection of herpes simplex virus and human papilloma virus in ophthalmic pterygium. Cornea (2001) 1.10
Photokeratitis and other phototoxic effects on the cornea and conjunctiva. Int J Toxicol (2003) 1.08
Increased oxidative DNA damage, 8-hydroxydeoxy- guanosine, in human pterygium. Eye (Lond) (2005) 1.07
Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis. J Biol Chem (2005) 1.07
Cellular aspects of photocarcinogenesis. Photochem Photobiol Sci (2005) 1.06
Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol (2003) 1.01
Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium. J Cell Mol Med (2007) 0.99
P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium. Mol Vis (2005) 0.94
Differential mechanisms of conjunctival cell death induction by ultraviolet irradiation and benzalkonium chloride. Invest Ophthalmol Vis Sci (2006) 0.93
Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol (1998) 0.92
Finding of conjunctival melanocytic pigmented lesions within pterygium. Histopathology (2006) 0.90
8-hydroxy-2'-deoxyguanosine, a major mutagenic oxidative DNA lesion, and DNA strand breaks in nasal respiratory epithelium of children exposed to urban pollution. Environ Health Perspect (1999) 0.90
Expression profiles of p63, p53, survivin, and hTERT in skin tumors. J Cutan Pathol (2004) 0.89
Connective tissue growth factor in pterygium: simultaneous presence with vascular endothelial growth factor - possible contributing factor to conjunctival scarring. Graefes Arch Clin Exp Ophthalmol (2002) 0.88
Expression of p63 in pterygium and normal conjunctiva. Cornea (2004) 0.86
Immunohistochemical study of human pterygium. Histol Histopathol (2002) 0.86
Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation. Exp Eye Res (2005) 0.83
Age-related differential expression of apoptosis-related genes in conjunctival epithelial cells. Acta Ophthalmol Scand (2005) 0.79
Ultraviolet-B radiation causes an upregulation of survivin in human keratinocytes and mouse skin. Photochem Photobiol (2004) 0.79
Overexpression of type I growth factor receptors in pterygium. Chin Med J (Engl) (2002) 0.78
Apoptosis: escaping strategies in human skin cancer (Review). Oncol Rep (2004) 0.77
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood (1999) 2.28
Oxytocin nasal spray in fibromyalgic patients. Rheumatol Int (2014) 2.22
Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol (1994) 2.01
Antiangiogenesis is produced by nontoxic doses of vinblastine. Blood (1999) 1.84
Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest (2003) 1.60
Bone marrow angiogenesis in multiple myeloma. Leukemia (2006) 1.47
Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest (1997) 1.39
Angiogenesis in rheumatoid arthritis. Histol Histopathol (2006) 1.39
Role of aquaporin-4 water channel in the development and integrity of the blood-brain barrier. J Cell Sci (2001) 1.28
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene (2007) 1.18
Bortezomib as an antitumor agent. Curr Pharm Biotechnol (2006) 1.17
Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma. Br J Haematol (2001) 1.16
Tissue distribution and membrane localization of aquaporin-9 water channel: evidence for sex-linked differences in liver. J Histochem Cytochem (2001) 1.12
Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization. J Cell Biol (1997) 1.11
Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer (1993) 1.09
High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. Eur J Endocrinol (2005) 1.08
A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies. Crit Rev Oncol Hematol (2013) 1.05
Risk factors for intraoperative femoral fractures during total hip replacement. Ann Chir Gynaecol (2000) 1.05
Macrophages and tumor angiogenesis. Leukemia (2007) 1.04
Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Br J Cancer (1999) 1.04
alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells. Exp Hematol (2001) 1.04
The mast cell: an active participant or an innocent bystander? Histol Histopathol (2004) 1.03
Macrophages in rheumatoid arthritis. Histol Histopathol (2007) 1.02
Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol (2003) 1.01
I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood (2000) 1.01
Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44. Am J Hematol (1995) 1.01
Vitamin D, thyroid hormones and muscle mass influence natural killer (NK) innate immunity in healthy nonagenarians and centenarians. Clin Exp Immunol (1999) 0.99
A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients. J Cell Mol Med (2007) 0.99
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. J Biol Chem (2001) 0.99
Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study. Neurology (2012) 0.98
Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat. J Biol Chem (2001) 0.97
Antiangiogenic activity of aplidine, a new agent of marine origin. Br J Cancer (2004) 0.97
Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int J Clin Lab Res (1998) 0.97
The effect of puberty on insulin resistance in obese children. J Endocrinol Invest (2009) 0.96
Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia (2003) 0.95
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients. Leukemia (2010) 0.95
Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer. Eur J Histochem (2011) 0.94
Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model. Diabetologia (2006) 0.94
Ultrasound in polycystic ovary syndrome--the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study. Hum Reprod (2007) 0.94
Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model. Leukemia (2011) 0.93
Altered blood-brain barrier development in dystrophic MDX mice. Neuroscience (2004) 0.93
Case control study on health-related quality of life in adult coeliac disease. Dig Liver Dis (2002) 0.93
Order and disorder in the vascular network. Leukemia (2004) 0.93
Endothelin-1, a regulator of angiogenesis in the chick chorioallantoic membrane. J Vasc Res (2001) 0.93
Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. Eur J Cancer (1997) 0.92
Bone marrow angiogenesis in patients with active multiple myeloma. Semin Oncol (2001) 0.92
Osteopontin is expressed and functional in human eosinophils. Allergy (2009) 0.92
Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat protein. Endothelium (2001) 0.92
Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A. Br J Cancer (2002) 0.91
Ultrastructural basis of the vessel wall differentiation in the chick embryo optic tectum. J Submicrosc Cytol (1985) 0.91
Vascular endothelial growth factor and its receptors in multiple myeloma. Leukemia (2003) 0.90
Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo. Leukemia (2011) 0.90
Finding of conjunctival melanocytic pigmented lesions within pterygium. Histopathology (2006) 0.90
Angiogenesis in lipoma: An experimental study in the chick embryo chorioallantoic membrane. Int J Mol Med (1999) 0.90
The role of eosinophil major basic protein in angiogenesis. Allergy (2008) 0.90
Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo. Leukemia (2004) 0.89
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. Cell Growth Differ (1996) 0.89
Targeting tumor lymphangiogenesis: an update. Curr Med Chem (2010) 0.89
Liver cell proliferation induced by a single dose of lead nitrate. Am J Pathol (1983) 0.89
Mast cells and basophils: a potential link in promoting angiogenesis during allergic inflammation. Int Arch Allergy Immunol (2009) 0.89
Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma. Histopathology (2007) 0.89
Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia (2004) 0.89
Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB. Genes Immun (2012) 0.89
The presence of acid mucopolysaccharides in viscous extrusions from the labellar and tarsal chemosensilla of Phormia regina (Meig.). Basic Appl Histochem (1980) 0.88
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment. Leukemia (2011) 0.88
Angiogenesis and progression in human melanoma. Dermatol Res Pract (2010) 0.88
VEGF concentration from plasma-activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model. J Cell Mol Med (2008) 0.88
The thymus is a site of mast cell development in chicken embryos. Anat Embryol (Berl) (2004) 0.87
Regional cortical thickness and cognitive functions in non-demented Parkinson's disease patients: a pilot study. Eur J Neurol (2011) 0.87
Antiangiogenesis by cyclosporine. Exp Hematol (1998) 0.86
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. Oncogene (2001) 0.86
Immunohistochemical study of human pterygium. Histol Histopathol (2002) 0.86
Vasculogenesis in the chick embryo optic tectum. Acta Anat (Basel) (1985) 0.86
Contribution of endothelial cells to organogenesis: a modern reappraisal of an old Aristotelian concept. J Anat (2007) 0.85
Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression. Dev Immunol (2000) 0.85
The Italian national trends in smoking initiation and cessation according to gender and education. J Prev Med Hyg (2009) 0.85
Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules. J Endocrinol Invest (2012) 0.85
Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process. Cancer Res (1999) 0.85
Smoking trends in Italy from 1950 to 2000. J Epidemiol Community Health (2006) 0.85
Subcellular localization of epidermal growth factor in human submandibular gland. Histochem J (2000) 0.84
Angiogenesis in vasculitides. Clin Exp Rheumatol (2008) 0.84
A histological and NMR study of the melon of the striped dolphin (Stenella coeruleoalba). Chem Phys Lipids (2004) 0.84
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma. Eur J Clin Invest (1999) 0.84
Acquisition of new "words" in normal subjects: a suggestion for the treatment of anomia. Brain Lang (2001) 0.84
Early alteration of synovial membrane in osteoarthrosis. Clin Rheumatol (1988) 0.84
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets. Oncogene (2011) 0.84
Experimental analysis and modelling of in vitro proliferation of mesenchymal stem cells. Cell Prolif (2009) 0.83
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas. Eur J Clin Invest (2002) 0.83